查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2004821

吸入麻醉剂市场：2026-2032年全球市场预测（依产品类型、年龄层、应用、最终用户及通路划分）

Inhalation Anesthetics Market by Product Type, Age Group, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，吸入麻醉剂市场价值将达到 17.5 亿美元，到 2026 年将成长至 18.9 亿美元，到 2032 年将达到 31.4 亿美元，复合年增长率为 8.71%。

主要市场统计数据
基准年 2025 17.5亿美元
预计年份：2026年 18.9亿美元
预测年份 2032 31.4亿美元
复合年增长率 (%) 8.71%

探索吸入麻醉剂，这些作用和进展正在重新定义现代外科手术和重症监护环境中的安全性、效率和治疗效果。

吸入麻醉剂近两个世纪以来一直是现代麻醉的基石。其发展历程从最初的乙醚和氯仿製剂演变为如今的先进药物，旨在快速起效、精准控制并最大限度地减少副作用。本文概述了改变外科手术护理的技术突破，使临床医生能够在各种手术环境中提供稳定、安全的麻醉。透过使用挥发性和气态麻醉化合物，医护人员可以根据每位患者的个别需求客製化镇静深度和苏醒模式。

对推动吸入麻醉效率、安全性和精确性新时代的技术、管理方法和法规结构的关键转变进行评估。

吸入麻醉剂领域正经历快速发展，主要得益于技术创新、日益严格的安全标准以及对环境永续性的需求。近年来，闭路麻醉输送系统得到了越来越广泛的应用，这些系统能够最大限度地减少废气排放并优化药物利用效率。这些系统与先进的监测工具相结合，使临床医生能够精确控制麻醉剂浓度、通气参数和患者血流动力学，从而降低术中不稳定的风险。

对 2025 年美国关税对吸入麻醉剂供应商的供应链、营运成本和策略采购决策的影响进行全面分析。

美国将于2025年实施的新关税为吸入麻醉剂的整个供应链带来了多方面的挑战，影响到原料采购、製造成本和分销经济效益。依赖进口前驱化学品的供应商面临不断上涨的投入成本，被迫重新评估其采购管道和合约条款。因此，製造商正在重新考虑其生产地点，并评估近岸外包和国内扩张的可能性，以减轻关税带来的负担。

我们将解读关键细分趋势，了解产品类型、年龄层、应用、最终用户和分销管道如何塑造吸入麻醉剂市场的不同细分领域。

要了解吸入麻醉剂产品满足临床需求的各种途径，需要深入研究市场。麻醉剂和挥发性麻醉剂之间的差异凸显了其製剂和给药方法上的根本差异。后者包括DESFLURANE、安氟烷、氟烷、Isoflurane和SEVOFLURANE等药物，每种药物具有独特的药物动力学特征和苏醒特性。这些产品层面的细微差别会影响临床医生的偏好和购买决策，尤其是在考虑起效速度和代谢负担之间的平衡时。

本分析考察了区域成长轨迹，揭示了美洲、欧洲、中东、非洲和亚太地区如何影响吸入麻醉领域的需求和策略重点。

区域趋势在塑造吸入麻醉剂市场机会和挑战相关人员发挥着至关重要的作用。在美洲，先进的医疗基础设施和大量的手术推动了对高品质麻醉剂相关给药系统的持续需求。美国和加拿大的监管机构优先考虑严格的安全和环境标准，创造了一个高度重视低排放量雾化器和药物製剂创新的环境。

对主要企业的策略性措施和竞争定位进行分析，重点在于塑造吸入麻醉剂产业格局的创新、合作和市场策略。

吸入麻醉剂领域的主要企业正采取多种策略来保持竞争优势并抓住新的机会。许多企业正在加速投资绿色化学和闭合迴路给药技术，以满足不断变化的环境法规和终端用户需求。与医疗设备製造商和软体开发商建立策略合作伙伴关係，有助于建立整合麻醉平台，将药物输送与先进的分析功能相结合，从而加强病患监测。

这为行业领导者提供了可操作的策略建议，以帮助他们应对吸入麻醉剂。

行业领导者可以透过采取多种切实可行的策略来巩固其市场地位。首先，优先研发低排放麻醉剂和闭路给药系统，有助于其产品在日益严格的环境法规下脱颖而出。投资配方科学和设备集成，有助于同时满足临床医生的偏好和永续性的要求。

在对吸入麻醉剂市场趋势的研究中，我们旨在阐明严谨的调查方法，以支持可靠的数据收集、分析、检验和洞察。

本分析所依据的研究采用了一种全面且多层次的调查方法，旨在确保研究结果的准确性、可靠性和相关性。主要研究工作包括对关键意见领袖（KOL）进行深入访谈，这些意见领袖包括麻醉师、采购经理、监管专家和医疗器材工程师。这些直接访谈使我们对临床偏好、营运挑战以及技术应用障碍有了更细緻的了解。

总结了关键趋势、技术进步、监管影响和竞争策略，这些因素将决定吸入麻醉剂产业的未来发展方向。

吸入麻醉剂产业正处于临床创新、不断变化的法规和永续性需求的交汇点。药物製剂和给药系统的技术进步正在提升安全性、营运效率和环境绩效。同时，诸如新的关税体系和排放指南等监管变化正在重塑供应链策略和成本结构。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 吸入麻醉剂市场：依产品类型划分

  • 气体麻醉剂
  • 挥发性麻醉剂
    • DESFLURANE
    • 安氟醚
    • 哈罗坦
    • Isoflurane
    • SEVOFLURANE

第九章：吸入麻醉剂市场：依年龄组别划分

  • 成人版
  • 老年人
  • 儿童

第十章 吸入麻醉剂市场：依应用领域划分

  • 麻醉诱导
  • 麻醉维持

第十一章 吸入麻醉剂市场：依最终使用者划分

  • 门诊手术中心（ASC）
  • 医院
  • ICU
  • 野战医院
  • 专科诊所
  • 动物医院

第十二章 吸入麻醉剂市场：依通路划分

  • 离线
  • 在线的

第十三章 吸入麻醉剂市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 吸入麻醉剂市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 吸入麻醉剂市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国吸入麻醉剂市场

第十七章：中国吸入麻醉剂市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AbbVie Inc.
  • Aetos Pharma Private Limited
  • Baxter International Inc.
  • Dechra Pharmaceuticals PLC
  • Dechra Veterinary Products
  • Draegerwerk AG & Co. KGaA
  • Fresenius Kabi AG
  • Halocarbon Life Sciences
  • Halocarbon Products Corporation
  • Hikma Pharmaceuticals PLC
  • Jiangsu Hengrui Medicine Co., Ltd.
  • Linde PLC
  • Lunan Pharmaceutical Group Co. Ltd.
  • Maruishi Pharmaceutical Co., Ltd.
  • NextSource Pharma
  • Pfizer Inc.
  • Piramal Critical Care Limited
  • Piramal Enterprises Limited
  • RAMAN WEIL
  • Troikaa Pharmaceuticals Ltd.
  • Yichang Humanwell Pharmaceutical Co., Ltd.
  • Zoetis Inc.
Product Code: MRR-742BD517FC4B

The Inhalation Anesthetics Market was valued at USD 1.75 billion in 2025 and is projected to grow to USD 1.89 billion in 2026, with a CAGR of 8.71%, reaching USD 3.14 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.75 billion
Estimated Year [2026] USD 1.89 billion
Forecast Year [2032] USD 3.14 billion
CAGR (%) 8.71%

Exploring the Transformative Role and Advancements in Inhalation Anesthetics That Are Redefining Safety Efficiency and Outcomes Across Contemporary Surgical and Critical Care Settings

Inhalation anesthetics have been a cornerstone of modern anesthesia practice for nearly two centuries, evolving from rudimentary ether and chloroform formulations to sophisticated agents designed for rapid onset, precise control, and minimal side effects. This introduction charts the technological breakthroughs that have transformed surgical care, enabling clinicians to deliver consistent, safe anesthesia in a wide range of operative settings. By harnessing volatile and gaseous anesthetic compounds, practitioners can tailor sedation depth and recovery profiles to individual patient needs.

A growing emphasis on patient safety and operational efficiency has spurred continuous innovation in drug design, delivery systems, and monitoring technologies. Anesthesiologists now benefit from advanced vaporizer devices, automated anesthesia workstations, and real-time respiratory analytics that collectively enhance precision and reduce perioperative risks. As global healthcare systems face rising demand for surgical interventions, the availability and reliability of inhalation anesthetics play a critical role in sustaining high-quality outcomes.

In this context, stakeholders across the supply chain-ranging from chemical manufacturers to hospital procurement teams-must navigate a complex interplay of regulatory requirements, environmental considerations, and cost pressures. Understanding the foundational science, product classifications, and clinical applications of inhalation anesthetics is essential for informed decision making. This executive summary lays out the essential landscape, spotlighting transformative shifts, regulatory impacts, segmentation insights, and regional patterns that define the current state and future trajectory of inhalation anesthesia.

Assessing the Pivotal Shifts in Technology Administration and Regulatory Frameworks That Are Driving a New Era of Efficiency Safety and Precision in Inhalation Anesthesia

The inhalation anesthetics landscape is undergoing rapid evolution driven by technological innovation, heightened safety standards, and environmental sustainability mandates. Recent years have seen the integration of closed-circuit anesthesia delivery systems that minimize waste gas emissions and optimize agent utilization. These systems, when paired with sophisticated monitoring tools, provide clinicians with granular control over anesthetic concentration, ventilation parameters, and patient hemodynamics, reducing the risk of intraoperative instability.

Regulatory agencies have responded to environmental concerns by updating guidelines on greenhouse gas emissions and occupational exposure limits, compelling manufacturers to refine agent formulations and delivery mechanisms. Concurrently, digital health platforms are enabling remote monitoring and analytics, creating opportunities for decentralized anesthesia clinics and tele-anesthesia services. Artificial intelligence algorithms are beginning to assist with predictive dosing models, further personalizing anesthesia plans and improving patient throughput.

These shifts not only enhance clinical outcomes but also reshape competitive dynamics, as companies invest heavily in R&D collaborations, strategic alliances, and intellectual property portfolios. The convergence of precision medicine principles with advanced anesthetic technologies heralds a new era of customized perioperative care, where safety, sustainability, and efficiency are paramount. As the industry navigates these transformative shifts, stakeholders must align innovation pipelines with emerging regulatory frameworks and evolving provider needs.

Analyzing the Comprehensive Effects of the 2025 United States Tariffs on Supply Chains Operational Costs and Strategic Sourcing Decisions Impacting Inhalation Anesthetic Providers

The implementation of new United States tariffs in 2025 has introduced multifaceted challenges across the inhalation anesthetics supply chain, affecting raw material procurement, manufacturing costs, and distribution economics. Suppliers reliant on imported precursor chemicals have experienced elevated input expenses, prompting strategic reassessments of sourcing channels and contract terms. In turn, manufacturers are reviewing their production footprints and evaluating nearshoring or domestic expansion to mitigate tariff burdens.

These cost pressures have implications for healthcare providers as well, who must balance budget constraints with the imperative to maintain access to high-quality anesthetic agents. Some institutions are exploring collaborative purchasing agreements and alternative formulations to manage expenditures without compromising patient care. Others are implementing inventory management platforms to optimize order quantities and reduce stock-out risks amid price volatility.

Over time, the cumulative tariff impact may accelerate diversification of global supply networks, encouraging partnerships with non-US suppliers or investment in emerging markets with favorable trade arrangements. Industry participants are also advocating for policy adjustments through trade associations, seeking clarity on tariff classifications and exploring exemptions for clinical applications. As the landscape stabilizes, the ability to adapt swiftly to regulatory cost shifts will distinguish resilient players and shape the long-term availability and affordability of inhalation anesthetic agents.

Decrypting Key Segmentation Dynamics to Understand How Product Types Age Groups Applications End Users and Distribution Channels Are Shaping Diverse Inhalation Anesthetic Market Niches

Understanding the diverse pathways through which inhalation anesthetic products serve clinical needs requires a close examination of market segmentation. The distinction between gaseous anesthetics and volatile anesthetics highlights fundamental differences in formulation and delivery, with the latter category encompassing agents such as Desflurane, Enflurane, Halothane, Isoflurane, and Sevoflurane, each offering unique pharmacokinetic profiles and recovery characteristics. These product-level nuances affect clinician preferences and purchasing decisions, especially when balancing onset speed against metabolic burden.

Age-based segmentation further reveals varying demand patterns, as adult patients often require higher throughput solutions, while geriatric populations benefit from agents with minimal hemodynamic impact and rapid recovery. Pediatric anesthesia, in contrast, demands formulations that allow for precise titration to ensure both safety and comfort during induction and emergence. The interplay between patient demographics and agent selection drives tailored inventory strategies within healthcare facilities.

Applications in induction of anesthesia versus maintenance of anesthesia underscore the operational divides in clinical workflows. Agents favored for rapid induction may differ from those optimized for prolonged surgical procedures, influencing the composition of anesthesia carts and pipeline setups in operating theaters. End users such as ambulatory surgical centers, hospitals, intensive care units, military or field hospitals, specialty clinics, and veterinary clinics each present distinct usage profiles, requiring suppliers to adapt packaging sizes, delivery devices, and training support accordingly.

Finally, distribution channels ranging from traditional offline medical distributors to emerging online platforms shape accessibility and purchasing convenience. While established healthcare systems may rely on long-standing contracts with brick-and-mortar suppliers, smaller clinics and veterinary practices are increasingly leveraging digital marketplaces for rapid order fulfillment and competitive pricing. This dual-channel environment necessitates flexible supply strategies to capture opportunities across all buyer segments.

Mapping Regional Growth Trajectories to Reveal How the Americas Europe Middle East and Africa and Asia Pacific Regions Are Influencing Demand and Strategic Focus in Inhalation Anesthesia

Regional dynamics play a pivotal role in shaping market opportunities and challenges for inhalation anesthetic stakeholders. In the Americas, advanced healthcare infrastructure and extensive surgical volumes drive sustained demand for premium anesthetic agents and connected delivery systems. Regulatory bodies in the United States and Canada emphasize stringent safety and environmental standards, fostering an environment where innovation in low-emission vaporizers and agent formulations is highly prized.

In Europe, the Middle East, and Africa, heterogeneity in healthcare access and reimbursement frameworks creates a spectrum of adoption rates. Western European nations lead in implementation of next-generation anesthesia platforms, while emerging economies within the region are gradually building capacity to support expanding surgical caseloads. Navigating diverse regulatory landscapes and procurement models necessitates localized strategies that address cost sensitivities and infrastructure limitations.

The Asia Pacific region exhibits one of the fastest growth trajectories, fueled by rising healthcare investments, expanding middle-class populations, and a surge in elective procedures. Markets in East Asia are characterized by rapid technology uptake and strong partnerships between global manufacturers and local distributors. In South and Southeast Asia, there is an increasing focus on capacity building through training programs and public-private collaborations to improve anesthesia safety and access.

Across all regions, the need to harmonize quality, affordability, and environmental compliance continues to drive cross-border alliances and knowledge exchange. Success in these diverse geographies hinges on the ability to tailor product offerings, service models, and regulatory engagement strategies to each region's unique healthcare ecosystem.

Illuminating Strategic Moves and Competitive Positioning of Leading Players to Highlight Innovations Collaborations and Market Approaches Shaping the Inhalation Anesthetics Industry Landscape

Leading companies in the inhalation anesthetics space are deploying a range of strategies to maintain competitive advantage and capture emerging opportunities. Many have accelerated investments in green chemistry and closed-loop delivery technologies to meet evolving environmental regulations and end user demands. Strategic collaborations with medical device firms and software developers are enabling integrated anesthesia platforms that combine agent delivery with advanced analytics for enhanced patient monitoring.

Some key players are expanding their geographic reach through acquisitions of regional distributors, establishing local manufacturing partnerships to reduce lead times and tariff exposures. Others are prioritizing research into novel anesthetic compounds with optimized safety profiles, targeting specific patient populations such as pediatrics or those with complex comorbidities. Robust clinical trial pipelines and real-world evidence studies underpin these innovation efforts, reinforcing brand credibility among healthcare practitioners.

To enhance customer engagement, leading suppliers offer comprehensive training programs, certification courses, and digital support tools that facilitate best practices in inhalation anesthetic administration. These value-added services not only improve clinical outcomes but also strengthen long-term relationships with high-volume accounts such as hospitals and ambulatory surgical centers. By aligning product development, regulatory strategy, and customer support, top companies continue to shape the future direction of the inhalation anesthetics industry.

Delivering Actionable Strategic Recommendations to Empower Industry Leaders in Navigating Regulatory Complexities Innovation Imperatives and Market Entry Challenges in the Inhalation Anesthetic Domain

Industry leaders can strengthen their market position by pursuing several actionable strategies. First, prioritizing research and development in low-emission anesthetic agents and closed-circuit delivery systems will differentiate offerings amid tightening environmental regulations. Investing in formulation science and device integration will help address both clinician preferences and sustainability imperatives.

Second, diversifying supply chains through nearshoring partnerships or multi-source agreements can mitigate the risks associated with tariff fluctuations and raw material shortages. Proactive engagement with trade associations and policy makers will also enable companies to shape regulatory outcomes and secure favorable treatment for critical clinical products.

Third, expanding digital capabilities by incorporating predictive analytics, remote monitoring, and e-commerce platforms will enhance customer accessibility and operational efficiency. Tailored training programs and tele-anesthesia services can improve adoption rates in emerging markets and specialized care settings.

Finally, forging strategic alliances with healthcare providers, academic institutions, and technology firms will accelerate innovation cycles and create integrated solutions that span drug delivery, monitoring, and outcome optimization. By leveraging collaborative ecosystems and embracing agile development methodologies, industry leaders will be better positioned to navigate evolving clinical needs and competitive pressures.

Elucidating the Rigorous Research Methodology That Underpins Reliable Data Collection Analysis Validation and Insights in the Study of Inhalation Anesthetics Market Dynamics

The research underpinning this analysis employed a comprehensive, multi-tiered methodology designed to ensure accuracy, reliability, and relevance. Primary research comprised in-depth interviews with key opinion leaders, including anesthesiologists, procurement managers, regulatory experts, and device engineers. These firsthand insights provided nuanced understanding of clinical preferences, operational challenges, and technology adoption barriers.

Secondary research involved a systematic review of scientific literature, patent filings, regulatory filings, and industry publications to map historical trends and emerging breakthroughs. Data sources were meticulously vetted with an emphasis on peer-reviewed journals, health authority databases, and credible industry reports. Quantitative data was triangulated across multiple reference points to validate consistency and identify discrepancies.

Analytical frameworks such as PEST analysis, SWOT evaluation, and segmentation matrices were applied to distill key market drivers, risks, and growth opportunities. Geographic and application-specific analyses provided deeper granularity, while scenario planning exercises modeled the potential impacts of regulatory changes, tariff implementations, and technology disruptions.

Quality control protocols included peer reviews by domain experts and quantitative checks to ensure data integrity. The resulting insights offer a well-rounded perspective on inhalation anesthetics, supporting informed decision making for stakeholders seeking actionable intelligence and strategic clarity.

Concluding Insights That Synthesize Critical Trends Technological Advancements Regulatory Impacts and Competitive Strategies Defining the Future Trajectory of the Inhalation Anesthetics Sector

The inhalation anesthetics sector stands at the intersection of clinical innovation, regulatory evolution, and sustainability imperatives. Technological advancements in agent formulations and delivery systems are enhancing safety, operational efficiency, and environmental performance. At the same time, regulatory shifts-exemplified by new tariff regimes and emission guidelines-are reshaping supply chain strategies and cost structures.

Segmentation analysis underscores the importance of product type differentiation, patient age cohorts, clinical applications, end user settings, and distribution channels, each of which influences demand patterns and competitive positioning. Regional insights reveal distinct trajectories in the Americas, Europe, Middle East & Africa, and Asia Pacific, highlighting the need for adaptive strategies tailored to local healthcare infrastructures and policy environments.

Leading companies are responding with innovation pipelines, strategic collaborations, and customer-centric services that bolster clinical outcomes and foster long-term partnerships. Actionable recommendations emphasize the value of sustainable R&D investments, supply chain diversification, digital transformation, and alliance building to navigate complexity and capitalize on emerging opportunities.

By integrating these multidimensional insights, stakeholders can chart a clear path forward, ensuring that inhalation anesthetics continue to advance patient care, operational excellence, and environmental stewardship. The culmination of this analysis provides a robust foundation for strategic planning and competitive differentiation in a rapidly evolving market landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Inhalation Anesthetics Market, by Product Type

  • 8.1. Gaseous Anesthetics
  • 8.2. Volatile Anesthetics
    • 8.2.1. Desflurane
    • 8.2.2. Enflurane
    • 8.2.3. Halothane
    • 8.2.4. Isoflurane
    • 8.2.5. Sevoflurane

9. Inhalation Anesthetics Market, by Age Group

  • 9.1. Adult
  • 9.2. Geriatric
  • 9.3. Pediatric

10. Inhalation Anesthetics Market, by Application

  • 10.1. Induction of Anesthesia
  • 10.2. Maintenance of Anesthesia

11. Inhalation Anesthetics Market, by End User

  • 11.1. Ambulatory Surgical Centers (ASCs)
  • 11.2. Hospitals
  • 11.3. ICUs
  • 11.4. Military/Field Hospitals
  • 11.5. Specialty Clinics
  • 11.6. Veterinary Clinics

12. Inhalation Anesthetics Market, by Distribution Channel

  • 12.1. Offline
  • 12.2. Online

13. Inhalation Anesthetics Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Inhalation Anesthetics Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Inhalation Anesthetics Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Inhalation Anesthetics Market

17. China Inhalation Anesthetics Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. AbbVie Inc.
  • 18.6. Aetos Pharma Private Limited
  • 18.7. Baxter International Inc.
  • 18.8. Dechra Pharmaceuticals PLC
  • 18.9. Dechra Veterinary Products
  • 18.10. Draegerwerk AG & Co. KGaA
  • 18.11. Fresenius Kabi AG
  • 18.12. Halocarbon Life Sciences
  • 18.13. Halocarbon Products Corporation
  • 18.14. Hikma Pharmaceuticals PLC
  • 18.15. Jiangsu Hengrui Medicine Co., Ltd.
  • 18.16. Linde PLC
  • 18.17. Lunan Pharmaceutical Group Co. Ltd.
  • 18.18. Maruishi Pharmaceutical Co., Ltd.
  • 18.19. NextSource Pharma
  • 18.20. Pfizer Inc.
  • 18.21. Piramal Critical Care Limited
  • 18.22. Piramal Enterprises Limited
  • 18.23. RAMAN WEIL
  • 18.24. Troikaa Pharmaceuticals Ltd.
  • 18.25. Yichang Humanwell Pharmaceutical Co., Ltd.
  • 18.26. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL INHALATION ANESTHETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INHALATION ANESTHETICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL INHALATION ANESTHETICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA INHALATION ANESTHETICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL INHALATION ANESTHETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY GASEOUS ANESTHETICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY GASEOUS ANESTHETICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY GASEOUS ANESTHETICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY DESFLURANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY DESFLURANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY DESFLURANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY ENFLURANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY ENFLURANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY ENFLURANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY HALOTHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY HALOTHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY HALOTHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY ISOFLURANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY ISOFLURANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY ISOFLURANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY SEVOFLURANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY SEVOFLURANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY SEVOFLURANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY INDUCTION OF ANESTHESIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY INDUCTION OF ANESTHESIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY INDUCTION OF ANESTHESIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY MAINTENANCE OF ANESTHESIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY MAINTENANCE OF ANESTHESIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY MAINTENANCE OF ANESTHESIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY ICUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY ICUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY ICUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY MILITARY/FIELD HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY MILITARY/FIELD HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY MILITARY/FIELD HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 133. GCC INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GCC INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. GCC INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 136. GCC INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GCC INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. GCC INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. GCC INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 154. G7 INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. G7 INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. G7 INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 157. G7 INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. G7 INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. G7 INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. G7 INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. NATO INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. NATO INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. NATO INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 164. NATO INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. NATO INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. NATO INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. NATO INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 170. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA INHALATION ANESTHETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 177. CHINA INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. CHINA INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 179. CHINA INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. CHINA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. CHINA INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)